Anaphylactic reaction to oxaliplatin: a case report.
Larzillière
I
I
Brandissou
S
S
Breton
P
P
Lingoungou
A
A
Gargot
D
D
Ramain
J P
JP
Harnois
C
C
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D000707:Anaphylaxis / Q000139:chemically induced*; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D012811:Sigmoid Neoplasms / Q000188:drug therapy
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil